Clark Estates Inc. NY Acquires 22,000 Shares of Bausch + Lomb Corporation (NYSE:BLCO)

Clark Estates Inc. NY lifted its position in shares of Bausch + Lomb Corporation (NYSE:BLCO - Free Report) by 3.7% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 622,000 shares of the company's stock after acquiring an additional 22,000 shares during the period. Bausch + Lomb makes up about 1.9% of Clark Estates Inc. NY's portfolio, making the stock its 12th largest holding. Clark Estates Inc. NY owned approximately 0.18% of Bausch + Lomb worth $9,019,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also added to or reduced their stakes in the stock. Alpine Global Management LLC acquired a new position in Bausch + Lomb in the 4th quarter valued at approximately $181,000. Commonwealth Equity Services LLC acquired a new position in Bausch + Lomb in the 4th quarter valued at approximately $181,000. Covestor Ltd acquired a new position in Bausch + Lomb in the 4th quarter valued at approximately $188,000. Orion Portfolio Solutions LLC acquired a new position in Bausch + Lomb in the 4th quarter valued at approximately $225,000. Finally, Tabor Asset Management LP acquired a new position in Bausch + Lomb in the 1st quarter valued at approximately $338,000. Institutional investors own 11.07% of the company's stock.

Bausch + Lomb Stock Down 0.8%

NYSE BLCO traded down $0.11 on Friday, hitting $13.52. 1,155,564 shares of the company were exchanged, compared to its average volume of 902,863. Bausch + Lomb Corporation has a 12 month low of $10.45 and a 12 month high of $21.69. The company has a market cap of $4.78 billion, a PE ratio of -17.33, a PEG ratio of 1.52 and a beta of 0.62. The stock has a fifty day moving average of $12.90 and a 200-day moving average of $13.91. The company has a current ratio of 1.55, a quick ratio of 0.96 and a debt-to-equity ratio of 0.76.

Bausch + Lomb (NYSE:BLCO - Get Free Report) last posted its quarterly earnings data on Wednesday, July 30th. The company reported $0.07 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.06 by $0.01. Bausch + Lomb had a negative net margin of 5.58% and a positive return on equity of 2.33%. The business had revenue of $1.28 billion during the quarter, compared to the consensus estimate of $1.25 billion. During the same quarter last year, the company posted $0.13 earnings per share. The firm's quarterly revenue was up 5.1% compared to the same quarter last year. As a group, analysts forecast that Bausch + Lomb Corporation will post 0.74 earnings per share for the current year.

Insider Transactions at Bausch + Lomb

In other Bausch + Lomb news, CEO Brent L. Saunders bought 22,000 shares of Bausch + Lomb stock in a transaction dated Thursday, May 22nd. The stock was purchased at an average price of $11.28 per share, for a total transaction of $248,160.00. Following the completion of the purchase, the chief executive officer directly owned 719,156 shares of the company's stock, valued at approximately $8,112,079.68. This trade represents a 3.16% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which is accessible through this link. Company insiders own 0.76% of the company's stock.

Analysts Set New Price Targets

Several equities research analysts have recently weighed in on the stock. Morgan Stanley increased their price objective on shares of Bausch + Lomb from $12.00 to $13.00 and gave the stock an "equal weight" rating in a research report on Friday. Wells Fargo & Company increased their price objective on shares of Bausch + Lomb from $12.00 to $15.00 and gave the stock an "equal weight" rating in a research report on Thursday. Needham & Company LLC reiterated a "hold" rating on shares of Bausch + Lomb in a research report on Thursday, April 24th. Barclays decreased their price objective on shares of Bausch + Lomb from $19.00 to $16.00 and set an "equal weight" rating for the company in a research report on Monday, June 9th. Finally, Royal Bank Of Canada decreased their price objective on shares of Bausch + Lomb from $18.00 to $17.00 and set an "outperform" rating for the company in a research report on Friday, April 4th. One equities research analyst has rated the stock with a sell rating, six have issued a hold rating and three have assigned a buy rating to the stock. According to MarketBeat.com, the stock has an average rating of "Hold" and a consensus price target of $15.56.

Bausch + Lomb Profile

Bausch + Lomb Corporation operates as an eye health company in the United States, Puerto Rico, China, France, Japan, Germany, the United Kingdom, Canada, Russia, Spain, Italy, Mexico, Poland, South Korea, and internationally. It operates in three segments: Vision Care, Pharmaceuticals, and Surgical. The Vision Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lens care products comprising over-the-counter eye drops, eye vitamins, and mineral supplements that address various conditions, such as eye allergies, conjunctivitis, dry eye, and redness relief.